期刊文献+

卵巢癌细胞IL-6、IL-8分泌与其他莫西芬敏感性及ER亚型及p160共激活因子表达关系的初步探讨 被引量:9

The relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen and the expression of estrogen receptor isoforms and p160 coactivators
下载PDF
导出
摘要 目的分析比较4种常见的人上皮性卵巢癌细胞系(A2780、CAOV-3、SKOV-3和ES-2)IL-6、IL-8分泌与其他莫西芬(Tamoxifen,TAM)敏感性及雌激素受体(estrogen receptor,ER)亚型及p160共激活因子表达的关系,为今后研究IL-6、IL-8诱导卵巢癌细胞对内分泌治疗产生耐药的机制奠定基础。方法 IL-6、IL-8的表达采用RT-PCR及ELISA法进行检测,卵巢癌细胞对TAM的敏感性采用MTT试验进行分析,ERα、ERβ及p160共激活因子的表达采用免疫印迹和RT-PCR技术进行检测。结果 4种卵巢癌细胞除A2780细胞外均组成性分泌IL-6和IL-8;4种细胞对TAM的敏感性不同,其中A2780细胞最敏感,CAOV-3、SKOV-3和ES-2细胞则有不同程度的耐药性(耐药倍数分别为4.98、3.75和2.66);这些细胞均不同程度地表达ERα,其中A2780细胞较低,CAOV-3和SKOV-3细胞较高,ES-2细胞居中;ERβ的表达情况则与ERα恰好相反;3种p160共激活因子mRNA的表达水平均以A2780细胞为最低,而ES-2、SKOV-3和CAOV-3细胞则依次升高。结论卵巢癌细胞IL-6、IL-8的自分泌水平与其对TAM的敏感性呈负相关,与其ERβ(而非ERα)及3种p160共激活因子的表达水平相一致。 We investigated the relationship of IL-6 and IL-8 secretion in four epithelial ovarian cancer cell lines (A2780,CAOV-3,SKOV-3 and ES-2) with their sensitivity to tamoxifen (TAM) and the expression of estrogen receptor (ER) isoforms and p160 coactivators,in an attempt to provide a basis for further investigating the mechanism of endocrine therapy resistance caused by IL-6 and IL-8 in ovarian cancer cells.Reverse transcription polymerase chain reaction (RT-PCR) and enzyme linked immunosorbent assay (ELISA) were performed to analyze the expression of IL-6 or IL-8.MTT assay was carried out to examine the sensitivity to TAM in ovarian cancer cells.The expressions of ER isoforms and p160 coactivators were detected by RT-PCR and Western blotting.Four kinds of ovarian cancer cells constitutively expressed IL-6 and IL-8 except A2780 cells.The sensitivity to TAM in four kinds of ovarian cancer cells was different.A2780 cells were the most sensitive,whereas CAOV-3,SKOV-3,and ES-2 cells were TAM-resistant at the different degree.Lower level of ERα was observed in A2780 cells,higher level was found in CAOV-3 and SKOV-3 cells,while moderate level was detected in ES-2 cells.The ERβ expression was opposite to the ERα expression.A gradual up-regulation of three p160 coactivators mRNA was detected in A2780,ES-2,SKOV-3 and CAOV-3 cells.We concluded that autocrine production levels of IL-6 and IL-8 in epithelial ovarian cancer cell lines are inversely associated with their sensitivity to TAM,and are in agreement with the expression of ERα (but not ERβ) and p160 coactivators in these cells.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第8期669-673,共5页 Immunological Journal
基金 天津市自然科学基金项目(08JCYBJC06900) 武警医学院科学技术研究重点项目(WJZ2007-1) 中国博士后科学基金面上项目(200804441177)
关键词 IL-6 IL-8 卵巢癌细胞 他莫西芬 ER亚型 p160共激活因子 IL-6 IL-8 Ovarian cancer cells TAM ER isoforms p160 coactivators
  • 相关文献

参考文献18

  • 1Penson RT, Kronish K, Duan Z, et al. Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel [J]. Int J Gynecol Cancer, 2000, 10 (1): 33-41.
  • 2Toutirais O, Chartier P, Dubois D, et al. Constitutive expression of TGF-beta, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma [J]. Eur Cytokine Netw, 2003, 14 (4): 246-255.
  • 3王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 4王越,杨洁,高燕,东莉洁,姚智.IL-6、IL-8上调卵巢癌细胞雄激素受体表达的作用分别依赖MAPK途径和Src活化[J].免疫学杂志,2008,24(4):424-429. 被引量:19
  • 5王越,吴健,刘昕,朱雅琴,孙维甲,李德金,王素青.外源性IL-8诱导卵巢癌细胞对顺铂和紫杉醇产生耐药的机制及相关信号转导通路的初步探讨[J].免疫学杂志,2010,26(4):299-303. 被引量:5
  • 6Bardin A, Hoffmann P, Boulle N, et al. Involvement of estrogen receptor b inovarian carcinogenesis [J]. Cancer Res, 2004, 64 (16): 5861-5869.
  • 7Myers E, Fleming FJ, Crotty TB, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer[J]. Br J Cancer, 2004, 91 (9): 1687-1693.
  • 8Osborne CK, Bardou V, Hopp TA, et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer [J]. J Natl Cancer Inst, 2003, 95 (5): 353-361.
  • 9Lindgren PR, Cajander S, Backstrom T, et aL Estrogen and progesterone receptors in ovarian epithelial tumors [J]. Mol Cell Endocrinol, 2004, 221(1/2): 97-104.
  • 10Chan KK, Wei N, Liu SS, et al. Estrogen receptor subtypes in ovarian cancer: a clinical correlation [J]. Obstet Gynecol, 2008, 111(1): 144-151.

二级参考文献43

  • 1王越,牛秀珑,郭小芹,吴健,朱雅琴,毛立群,屈野,李覃.卵巢癌细胞IL-6、IL-8分泌与其化疗敏感性及耐药相关基因和凋亡抑制基因表达关系的初步探讨[J].免疫学杂志,2009(4):436-441. 被引量:11
  • 2王越,杨洁,高燕,牛文彦,姚智.DHT、IL-6和IL-8对卵巢癌细胞体外增殖的作用[J].中华微生物学和免疫学杂志,2006,26(2):115-120. 被引量:6
  • 3王越,杨洁,高燕,牛文彦,姚智.卵巢癌细胞IL-6、IL-8及其受体表达的研究[J].免疫学杂志,2006,22(5):475-479. 被引量:16
  • 4Penson RT, Kronish K, Duan Z, et al. Cytokines IL-lbeta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel [J]. Int J Gynecol Cancer, 2000, 10(1): 33-41.
  • 5Merritt WM, Lin YG, Spannuth WA. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth [J]. J Natl Cancer Inst, 2008, 100(5): 359-372.
  • 6Toutirais O, Chartier P, Dubois D, et al. Constitutive expression of TGF-beta, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma [J]. Eur Cytokine Netw, 2003, 14 (4): 246-255.
  • 7Wang Y, Yang J, Gao Y, et al. Reciprocal regulation of 5al- pha-Dihydrotestosterone, Interleukin-6 and Interleukin-g during proliferation of epithelial ovarian carcinoma[J]. Cancer Biol Ther, 2007, 6 (6): 864-871.
  • 8Duan Z, Feller A J, Penson RT, et al. Discovery of differen- tially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) -6, IL-8,and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype [J]. Clin Cancer Res, 1999, 5 (11): 3445-3453.
  • 9Kamazawa S, Kigawa J, Kanamori Y, et al. Multidrug resistance gene-I is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer [J]. Gynecol Oncol, 2002, 86(2): 171-176.
  • 10Naniwa J, Kigawa J, Kanamori Y, et al. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2007, 17(1): 76-82.

共引文献32

同被引文献64

引证文献9

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部